1. Home
  2. KITT vs GRI Comparison

KITT vs GRI Comparison

Compare KITT & GRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nauticus Robotics Inc.

KITT

Nauticus Robotics Inc.

HOLD

Current Price

$0.69

Market Cap

5.3M

Sector

Industrials

ML Signal

HOLD

Logo GRI Bio Inc.

GRI

GRI Bio Inc.

HOLD

Current Price

$1.99

Market Cap

4.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KITT
GRI
Founded
2014
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3M
4.5M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
KITT
GRI
Price
$0.69
$1.99
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$160.00
AVG Volume (30 Days)
452.6K
817.2K
Earning Date
04-16-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
71.55
N/A
EPS
N/A
N/A
Revenue
$11,434,959.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
33.10
N/A
52 Week Low
$0.39
$0.18
52 Week High
$4.48
$6.70

Technical Indicators

Market Signals
Indicator
KITT
GRI
Relative Strength Index (RSI) 34.89 51.80
Support Level $0.46 $0.20
Resistance Level $1.03 $2.53
Average True Range (ATR) 0.07 0.28
MACD -0.02 0.06
Stochastic Oscillator 16.85 21.06

Price Performance

Historical Comparison
KITT
GRI

About KITT Nauticus Robotics Inc.

Nauticus Robotics Inc is a technology-driven company specializing in the development of fully electric autonomous robotic solutions for subsea applications. Its portfolio includes autonomous underwater vehicles (AUVs), electric robotic manipulators, a platform-agnostic robotic operating system, and related engineering, consulting and prototype services. The Company's solutions enable autonomous operations for both commercial and defense sectors, with alignment to offshore energy and national security interests. Its addressable markets include upstream, midstream and downstream oil and gas, defense, offshore renewables, seafloor telecommunications, aquaculture, port security, oceanographic research and subsea mining, with current focus on oil and gas operations and defense applications.

About GRI GRI Bio Inc.

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

Share on Social Networks: